APA引用形式

Verstovsek, S., Talpaz, M., Ritchie, E., Wadleigh, M., Odenike, O., Jamieson, C., . . . Mesa, R. A. (2017). A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis. Leukemia.

シカゴスタイル引用形

Verstovsek, S., M. Talpaz, E. Ritchie, M. Wadleigh, O. Odenike, C. Jamieson, B. Stein, T. Uno, , R A. Mesa. "A Phase I, Open-label, Dose-escalation, Multicenter Study of the JAK2 Inhibitor NS-018 in Patients With Myelofibrosis." Leukemia 2017.

MLA引用形式

Verstovsek, S., et al. "A Phase I, Open-label, Dose-escalation, Multicenter Study of the JAK2 Inhibitor NS-018 in Patients With Myelofibrosis." Leukemia 2017.